+313.5%
OKLO vs EMR
+77.7%
+235.8%
-78.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | EMR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.6% | +1.7% | +1.9% | +2.4% |
| 7D | +2.8% | -1.5% | +4.3% | +4.0% |
| 30D | -4.0% | -5.6% | +1.6% | +0.1% |
| 3M | -36.9% | +7.9% | -44.8% | -40.2% |
| 6M | -37.1% | +6.0% | -43.2% | -39.1% |
| YTD | -42.5% | +16.4% | -58.9% | -47.0% |
| 1Y | -40.7% | +16.6% | -57.3% | -45.0% |
| 3Y | +299.1% | +62.9% | +236.3% | +240.3% |
| 5Y | +317.3% | +60.1% | +257.2% | +259.1% |
| All | +313.5% | +77.7% | +235.8% | +250.8% |
Cumulative growth
Daily Returns
Daily percentage return beside EMR.
Daily Out/Under-Performance
Portfolio return minus EMR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EMR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded EMR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling